Arrowhead Research reported $44.37M in Net Income for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Agios Pharmaceuticals AGIO:US $ -94.77M 0.15M
Alnylam Pharmaceuticals ALNY:US $ -240.34M 18.12M
Anika Therapeutics ANIK:US $ -2.93M 2.86M
Arrowhead Research ARWR:US $ 44.37M 107.24M
Cerulean Pharma CERU:US $ -8.4M 1.14M
Heron Therapeutics HRTX:US $ -63.89M 9.24M
Intercept Pharmaceuticals ICPT:US $ -17.28M 19M
IONIS PHARMACEUT IONS:US $ -65.17M 289.78M
Ligand Pharmaceuticals LGND:US $ -15.38M 9.97M
Merk MRK:US $ 4310M 552M
Mirati Therapeutics MRTX:US $ -188.39M 11.23M
Moderna Inc MRNA:US 3.66B 1.21B
Nektar Therapeutics NKTR:US $ -90.39M 55.25M
Novartis NOVN:VX SF 2222M 14086M
Opko Health OPK:US $ -55.43M 18.34M
Sarepta Therapeutics SRPT:US $ -105.02M 16.96M
Spectrum Pharmaceuticals SPPI:US $ -15.44M 24.27M
Tg Therapeutics TGTX:US $ -69.01M 24.32M
Ultragenyx Pharmaceutical RARE:US $ -152.32M 29.86M
Vertex Pharmaceuticals VRTX:US $ 762.1M 8.01M
Xencor XNCR:US $ 23.59M 49.47M
YTE INCY:US $ 37.99M 525.86M